Literature DB >> 1964077

A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors.

K Furukawa1, Y Yamaguchi, E Ogawa, K Shigesada, M Satake, Y Ito.   

Abstract

A mutant of polyomavirus, F9-5000, capable of growing in F9 cell [M. Vasseur et al., J. Virol., 43: 800-808, 1982 (1)], has a deletion in the enhancer from nucleotide 5119 to nucleotide 5142. The oligonucleotide corresponding to the deleted region (delta F9-5000 element) showed silencer activity on gene expression in F9 cells. Mobility shift assay revealed a nuclear factor, PEBP4, in F9 nuclear extract which bound to the delta F9-5000 element. Mutations introduced into the PEBP4 binding site specifically abolished its binding as well as the inhibitory effect on gene expression. After F9 cells were induced to differentiate, two more factors, PEBP2 and PEBP1, a member of AP1 family, became detectable in addition to PEBP4, and at the same time the delta F9-5000 element lost silencer activity and acquired an enhancer activity. The recognition sequence of PEBP2 as well as that of PEBP1 overlapped with that of a repressor, PEBP4. PEBP4 and PEBP3, a factor related to PEBP2, were shown to compete for binding to delta F9-5000. Interplay of a ubiquitous negative factor and differentiation-induced positive factors may represent one aspect of the gene regulation during embryonic development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964077

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  23 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.

Authors:  J R Flanagan; M Murata; P A Burke; Y Shirayoshi; E Appella; P A Sharp; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.

Authors:  H M Schmidt; G Steger; H Pfister
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer.

Authors:  Y Kamachi; E Ogawa; M Asano; S Ishida; Y Murakami; M Satake; Y Ito; K Shigesada
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

Review 5.  Negative regulation of transcription in eukaryotes.

Authors:  A R Clark; K Docherty
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

6.  PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene.

Authors:  E Ogawa; M Maruyama; H Kagoshima; M Inuzuka; J Lu; M Satake; K Shigesada; Y Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

7.  NF-kappa B-independent activation of beta-interferon expression in mouse F9 embryonal carcinoma cells.

Authors:  M J Ellis; S Goodbourn
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

8.  Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells.

Authors:  M E Martin; X Y Yang; W R Folk
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

9.  cDNA cloning and functional characterization of a meiosis-specific protein (MNS1) with apparent nuclear association.

Authors:  K Furukawa; H Inagaki; T Naruge; S Tabata; T Tomida; A Yamaguchi; M Yoshikuni; Y Nagahama; Y Hotta
Journal:  Chromosome Res       Date:  1994-03       Impact factor: 5.239

10.  Analysis of transcription factors binding to the duplicated PEA1 and PEA3 sites that are required for polyomavirus mutant expression in PCC4 embryonic carcinoma cells.

Authors:  J Y Nothias; R Weinmann; D Blangy; F Melin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.